ArticlePLoS genetics2026
Barrier-to-autointegration factor protects against the cGAS-STING response to chromatin bridges.
Article in PLoS genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellular damage or stress can lead to disorganization, mislocalization or damage to self-DNA that can activate intracellular innate immune response mechanisms. Micronuclei, such as can occur following mitotic defects, have been proposed as a source of DNA capable of activating the cGAS-STING pathway, resulting in IRF3-dependent proinflammatory transcription. However, to what extent micronuclei per se or other concurrent defects contribute to the cGAS-STING response remains unclear. To better understand the ability of post-mitotic defects to induce this response, we compared the effects resulting from inhibition of the Spindle-Assembly Checkpoint (through MPS1 inhibition) or interference with nuclear reassembly (through inactivation of BAF). We found that combining both perturbations synergistically enhances the cGAS-STING response. This effect is not due to an increase in post-mitotic nuclear deformations including micronucleation and lobulation but instead correlates with an increase in destabilized chromatin bridges resulting in structures that potently recruit cGAS. Our results suggest that by stabilizing chromatin bridges, BAF contributes to preventing their degeneration into cGAS-activating chromatin structures. This work helps better understand how the innate immune system detects mitotic defects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.